Platelets, traditionally recognised for their role in haemostasis, have emerged as active participants in the aetiology and progression of neurodegenerative disorders through mechanisms that bridge ...

A team from Würzburg has fundamentally changed our understanding of platelet biology. The researchers demonstrate that the surface protein integrin αIIbβ3 is not only a key molecule in blood clotting, ...

In the article by Kulecki et al, 1 published in the current issue of Polish Archives of Internal Medicine, the authors ...

Glycoprotein VI, or GPVI for short, is a surface receptor found exclusively on platelets and their precursor cells, ...

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...

Platelets are small types of blood cells that prevent excessive bleeding. It’s possible to develop low or high platelet counts related to a number of health conditions. Platelets are one of the main ...

A research team from Experimental Biomedicine I at Würzburg University Hospital (UKW) presents a novel approach to prevent arterial thrombosis and inflammatory tissue damage, so-called ...

Thrombocytopenia is an atypically low platelet count. Acquired thrombocytopenia is caused by conditions that develop throughout your life instead of genes inherited from birth. Acquired ...